mRNA

NVS
Biotech

Novartis pens $7.8B deal for Abogen's in vivo autoimmune TCE

The deal, which includes up to $7.2 billion in milestones, comes weeks after Novartis paused an autoimmune CAR-T program over three deaths.
Nick Paul Taylor Oct 2, 2026 4:24am
Graphic portrayal of a cancer vaccine releasing therapeutic material that latches onto tumors

Have Moderna, Merck kicked off a 'personalized med revolution'?

Sep 11, 2026 9:00am
GSK

GSK plans phase 3 after mRNA flu vaccine beats standard shots

Sep 1, 2026 5:43am
Comedy and tragedy masks on red curtain background

BioNTech, Genentech cancel ph. 2 test of personalized cancer vax

Aug 28, 2026 1:50pm
University of Toronto downtown sign

With mRNA back in the spotlight, tRNA shows potential

Aug 27, 2026 2:00pm
Moderna ESMO

Merck-Moderna vaccine data spur talk of Keytruda-like impact

Aug 20, 2026 9:25am